# Ciclesonide for the Treatment of Airway Hyperresponsiveness

> **NCT00826969** · PHASE4 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 64 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00826969
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2010-07
- **Final completion:** 2011-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2016-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00826969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00826969, "Ciclesonide for the Treatment of Airway Hyperresponsiveness". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00826969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*